22 24-months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

✍ Scribed by Ari Zimran; G. Altarescu; C. Fratazzi; R. Mensah; D. Elstein

• Book ID: 116988079
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 46 KB
• Volume: 92
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2007.08.027